Herbal Remedies of Hypercoagulability – Causes, Symptoms, Diagnosis & Treatment

Abstract

Hypercoagulability, also known as thrombophilia, is an exaggerated operational state of the hemostatic system characterised by an increased tendency of the blood to form intravascular clots. Under normal physiological conditions, hemostasis maintains a delicate equilibrium between procoagulant mechanisms and anticoagulant control networks to prevent localised blood loss while preserving blood fluidity. When this balance is disrupted toward excessive coagulation, thrombosis can occur within the arterial, venous, or microvascular networks, leading to life-threatening clinical sequelae such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. This condition arises from a complex interaction between inherited genetic mutations and acquired clinical risk factors, ultimately leading to endothelial dysfunction, stasis, or hypercoagulable blood states—collectively described by Virchow’s triad. Diagnostic evaluation relies on specialised laboratory assays, risk-stratification models, and diagnostic imaging. Contemporary management centers on targeted anticoagulant therapies, whereas Ayurvedic medicine offers an integrative perspective viewing hypercoagulability through the lens of Rakta Dushya, Pitta-Kapha dyscrasias, and impaired microcirculation (Srotorodha).

Introduction

Blood clotting is an essential protective mechanism. When a blood vessel is injured, platelets adhere to the damaged area and coagulation proteins generate fibrin, producing a clot that limits blood loss. After healing, natural anticoagulant and fibrinolytic mechanisms prevent the clot from growing unnecessarily and help remove it. Hypercoagulability develops when this physiological balance becomes shifted toward excessive coagulation. The resulting tendency to form thrombosis can occur in otherwise healthy individuals or in association with an underlying genetic or acquired condition.
The term thrombophilia is often used when referring to an increased predisposition to thrombosis, particularly when the tendency is related to identifiable inherited or acquired abnormalities. Importantly, having a hypercoagulable state does not mean that a person definitely has a blood clot. Rather, it increases the likelihood of developing one under particular circumstances.
The clinical significance depends on the type of thrombosis, its location, the extent of vascular obstruction, and whether a clot travels to another part of the circulation.

What Causes Hypercoagulability?

The causes of hypercoagulability are broadly divided into inherited (congenital) and acquired conditions. In many patients, thrombosis develops through a combination of genetic susceptibility and secondary triggers such as surgery, immobilisation, inflammation, or hormonal exposure.

Inherited Causes

Factor V Leiden Mutation

A common inherited thrombophilia in people of European ancestry. It causes resistance to activated protein C, allowing factor V to remain active longer and promoting continued coagulation.

Prothrombin G20210A Mutation

This genetic variant increases circulating prothrombin levels, resulting in greater thrombin-generation potential and an increased risk of venous thrombosis.

Antithrombin Deficiency

A rare inherited disorder involving reduced antithrombin activity or levels. Since antithrombin naturally inhibits thrombin and factor Xa, its deficiency promotes excessive clotting.

Protein C and Protein S Deficiencies

These natural anticoagulant proteins help regulate activated clotting factors. Their deficiency reduces control over coagulation and increases thrombotic risk.

Hyperhomocysteinemia

Elevated homocysteine levels can contribute to endothelial dysfunction and may increase thrombotic risk, particularly in the presence of other risk factors.

Acquired Causes

Antiphospholipid Syndrome (APS)

An autoimmune disorder associated with antiphospholipid antibodies, including lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein I antibodies. These promote coagulation through effects on endothelial cells, platelets, and natural anticoagulant pathways.

Malignancy

Cancer can increase coagulation through tumour-derived tissue factor, procoagulant substances, and inflammatory mediators, contributing to conditions such as cancer-associated thrombosis.

Immobilisation and Surgery

Prolonged bed rest, paralysis, long-distance travel, and major surgery cause venous stasis and activate coagulation, increasing the risk of thrombosis.

Hormonal Factors

Estrogen-containing contraceptives, hormone replacement therapy, and pregnancy alter coagulation by increasing several clotting factors and reducing some natural anticoagulant activity.

Chronic Inflammatory and Systemic Diseases

Inflammatory bowel disease, systemic lupus erythematosus, nephrotic syndrome, and severe infections can promote a prothrombotic state through inflammation, endothelial activation, and impaired anticoagulant mechanisms.

Pathophysiology

Hypercoagulability operates through Virchow’s triad: endothelial injury, stasis, and hypercoagulability. When the endothelium is injured or activated by inflammatory cytokines, it downregulates protective molecules (thrombomodulin, nitric oxide) and exposes subendothelial tissue factor. Tissue factor initiates the extrinsic clotting pathway. Concurrently, venous stasis prevents the clearance of activated clotting enzymes, allowing localised thrombin concentrations to build up and convert fibrinogen into an insoluble fibrin mesh. At the cellular level, hypercoagulability propagates when natural braking mechanisms fail. Deficiencies or resistance in protein C, protein S, or antithrombin allow the amplification phase of coagulation to proceed unchecked, creating cross-linked fibrin clots that occlude vessels and cause downstream ischemia.

Signs and Symptoms

Symptoms depend on the location and extent of the vascular occlusion:

Venous Thromboembolism

• Deep Vein Thrombosis (DVT): Unilateral limb swelling, warmth, erythema, localised tenderness, and calf pain.
• Pulmonary Embolism (PE): Sudden dyspnea, pleuritic chest pain, tachypnea, tachycardia, hemoptysis, and syncope.

Arterial Thrombosis

• Ischemic Stroke: Abrupt focal neurological deficits (facial drooping, unilateral weakness, speech difficulty).
• Myocardial Infarction: Severe substernal chest pressure, diaphoresis, and shortness of breath.
• Peripheral Arterial Occlusion: Acute pain, pallor, pulselessness, paresthesia, and coldness in the affected limb.

Diagnosis

Evaluation relies on clinical probability, non-invasive imaging, and laboratory tests:

Imaging

Duplex Ultrasonography for assessing DVT; CT Pulmonary Angiography (CTPA) for confirming PE; and MR Venography for atypical site thrombosis (e.g., cerebral or visceral veins).

Laboratory Testing

• D-Dimer: Elevated levels indicate active fibrin turnover (useful for ruling out VTE in low-probability cases).
• Coagulation Studies: Baseline PT, aPTT, and fibrinogen levels.
• Thrombophilia Screening: DNA testing for Factor V Leiden and Prothrombin variants; functional assays for Antithrombin, Protein C, and Protein S; and antiphospholipid antibody panels.

Modern Management

Treatment focuses on resolving acute clots and preventing recurrence:

Acute Phase

Rapid-acting parenteral anticoagulants like Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin, or Fondaparinux are initiated immediately.

Maintenance Phase

Direct Oral Anticoagulants (DOACs) such as apixaban or rivaroxaban are preferred for long-term therapy due to their safety profile and lack of mandatory monitoring. Vitamin K antagonists (Warfarin) are used as an alternative, requiring routine INR checks.

Thrombolytic Interventions

Systemic or catheter-directed thrombolysis (e.g., tPA) or mechanical thrombectomy is reserved for life-threatening PE or severe limb ischemia.

Ayurveda Insight

Ayurveda interprets hypercoagulability through the disruption of Rakta Dhatu (blood tissue), Pitta, and Kapha Doshas, leading to Srotorodha (obstruction of vascular channels). Poor diet, stress, and systemic inflammation aggravate Pitta and Kapha. Aggravated Pitta creates heat and toxicity in the blood (Rakta Dushti), while Kapha imparts a thick, sticky (Picchila) quality. Simultaneously, Vata causes dryness and roughness in the vascular walls (Srotas). This combined imbalance alters blood viscosity, slowing circulation and obstructing flow (Srotorodha).
Ayurvedic care centres on purifying the blood (Raktashodhaka) and clearing channels (Srotoshodhana):

• Panchakarma Therapies: Virechana (therapeutic purgation) eliminates excess Pitta and systemic toxins (Ama). Historically, Jalaukavacharana (leech therapy) was applied locally to clear static blood—notably, leech saliva contains hirudin, a potent direct thrombin inhibitor used in modern medicine.

Herbal Remedies for Hypercoagulability by Planet Ayurveda

Planet Ayurveda is a wellness brand rooted in the traditional principles of Ayurveda. It offers a wide range of herbal formulations prepared with carefully selected natural ingredients. The brand focuses on supporting various aspects of health, including digestion, immunity, joint health, heart wellness, and women’s well-being. Planet Ayurveda combines classical Ayurvedic knowledge with modern quality standards to create convenient wellness products. Its formulations are designed to complement healthy lifestyle practices and daily self-care. The brand promotes a holistic approach that considers overall physical and mental well-being. Planet Ayurveda aims to make traditional Ayurvedic wellness accessible and practical for modern lifestyles. Here, we will discuss some effective Ayurvedic formulation that helps in the management of Hypercoagulability. Let’s start!

1. Gotu Kola Capsules
2. Arjuna Capsules
3. Chandraprabha Vati
4. Curcumin Capsules

Herbal Remedies for Hypercoagulability

Product Description

1. Gotu Kola Capsules

Gotu Kola Capsules containing Centella asiatica provide supportive Ayurvedic care for vascular health in people with hypercoagulability. Gotu Kola is traditionally used to support healthy circulation and the integrity of blood vessels. Its triterpenoid compounds, particularly asiaticoside and madecassoside, are associated with antioxidant and vascular-supportive activity. By supporting endothelial health and normal connective-tissue function, it contributes to maintaining healthy blood-vessel structure. It also supports tissue recovery and microcirculatorBlood function. From an Ayurvedic perspective, Gotu Kola is valued for supporting Rakta Vaha Srotas (channels of blood circulation) and maintaining healthy circulation.

Dosage: 1 Capsule twice daily after a meal with Plain water.

2. Arjuna Capsules

Arjuna Capsules containing Terminalia arjuna provide supportive cardiovascular care in hypercoagulability by helping maintain the structural and functional health of blood vessels. Its antioxidant constituents help protect the vascular endothelium from oxidative stress, an important factor in maintaining normal vascular function. Arjuna also supports healthy cardiac pumping and circulation, promoting efficient movement of blood through the vascular system. Its cardioprotective activity contributes to maintaining vascular resilience when circulatory stress is present. From an Ayurvedic perspective, Arjuna is considered Hridya (provides strength to the heart) and supports the healthy functioning of Rakta Vaha Srotas (channels of blood circulation). This makes it relevant as supportive care for maintaining vascular integrity and healthy circulation in individuals with an increased tendency toward clot formation.

Dosage: 1 Capsule twice daily after a meal with Plain water.

3. Chandraprabha Vati

Chandraprabha Vati, containing ingredients such as Shilajit, Guggul, Kapoor, Vacha, Mustak, and several other classical Ayurvedic components, supports metabolic and circulatory balance relevant to hypercoagulability. Guggul contributes anti-inflammatory and lipid-metabolism-supportive properties, helping maintain a healthier vascular environment. Shilajit is traditionally valued for supporting cellular energy and overall tissue function. Its antioxidant activity helps protect vascular tissues from oxidative stress, which is relevant to endothelial health. The formulation also supports efficient circulation and healthy tissue metabolism. From an Ayurvedic perspective, Chandraprabha Vati helps maintain proper Srotas (Channels) function and supports balanced movement of Vata through the body. These combined actions make it a supportive formulation for maintaining vascular and metabolic health in individuals with increased thrombotic risk.

Dosage: 2 tablets twice daily after a meal with Plain water.

4. Curcumin Capsules

Curcumin Capsules, containing concentrated curcuminoids from Curcuma longa, provide supportive vascular care relevant to hypercoagulability through their anti-inflammatory and antioxidant properties. Curcumin helps regulate inflammatory signalling pathways involved in endothelial activation and vascular stress. It also supports endothelial function by reducing oxidative damage to vascular tissues. By promoting a healthier vascular environment, curcumin contributes to maintaining normal blood-flow dynamics. Its effects on inflammatory mediators are particularly relevant when chronic inflammation contributes to an increased thrombotic tendency. Curcumin also supports healthy platelet and vascular responses as part of normal circulatory function. From an Ayurvedic perspective, turmeric (Haridra) is valued for supporting Rakta Shuddhi (Blood purification) and maintaining healthy Rakta Vaha Srotas (channels of blood circulation).

Dosage: 1 Capsule twice daily after a meal with Plain water.

Conclusion

Hypercoagulability is an increased tendency of the blood to form abnormal clots and may result from inherited thrombophilia, cancer, autoimmune disease, pregnancy, hormonal exposure, surgery, prolonged immobility, or other acquired conditions. The condition itself may remain silent until a thrombus develops, making recognition of risk factors important. DVT and pulmonary embolism are major manifestations of venous thrombosis, while arterial thrombosis can lead to serious events such as ischemic stroke or myocardial infarction. Diagnosis requires appropriate clinical assessment, laboratory testing, and imaging rather than relying on symptoms alone. Modern management centres on anticoagulation when thrombosis is present or prevention is indicated, together with treatment of the underlying cause and modification of risk factors. Ayurveda can provide a complementary perspective through individualised attention to Rakta, Srotas, diet, lifestyle, and systemic balance, but suspected or confirmed thrombosis requires appropriate medical evaluation and evidence-based treatment.